{"id":"CHEMBL1079593","canonicalSmiles":"O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1[C@@H]1CCOc2c(F)cccc21","inchiKey":"DBXGGXLBTWZXBB-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VS-5584","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VS-5584","Vs 5584","Vs-5584"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000588","EFO_0000574","MONDO_0024880"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1082607","canonicalSmiles":"O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O","inchiKey":"XTZNCVSCVHTPAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SALMETEROL XINAFOATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1263","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Serevent"],"synonyms":["GR 33343 G","GR-33343 G","GR-33343X","LIPO-202","Salmeterol 1-hydroxy-2-naphthoate","Salmeterol xinafoate"],"crossReferences":{"DailyMed":["salmeterol%20xinafoate"],"PubChem":["144204822","170465397","26753648","29215171","50107004","56320805","56320806","90341116"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0007183","EFO_0000464","EFO_0006505","EFO_0010638","MONDO_0004979","EFO_0000341","HP_0025428","EFO_0001073"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 5 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1088751","canonicalSmiles":"CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1","inchiKey":"KCAJXIDMCNPGHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PH-797804","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PH-797804","PHA-797804","Ph-797804"],"crossReferences":{"PubChem":["103905624","137276009"],"drugbank":["DB07941"],"chEBI":["82715"]},"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0041052","EFO_0000341","MONDO_0005178","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1100","canonicalSmiles":"CCC1(C)OC(=O)N(C)C1=O","inchiKey":"VQASKUSHBVDKGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARAMETHADIONE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paradione"],"synonyms":["Isoethadione","NSC-760129","Paramethadione"],"crossReferences":{"Wikipedia":["Paramethadione"],"drugbank":["DB00617"],"chEBI":["7921"]},"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949 and is indicated for epilepsy."}
{"id":"CHEMBL113537","canonicalSmiles":"O=C(CCCCCCC(=O)C(F)(F)F)Nc1ccccc1","inchiKey":"KRCXZGYVOZSCSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113537","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07553"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160594","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1I","inchiKey":"WXFYBFRZROJDLL-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160594","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02324"]},"childChemblIds":["CHEMBL572275"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116296","canonicalSmiles":"Ic1ccccc1","inchiKey":"SNHMUERNLJLMHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOBENZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iodo-Benzene","Iodobenzene"],"crossReferences":{"Wikipedia":["Iodobenzene"],"drugbank":["DB02252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117651","canonicalSmiles":"Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCCCCc1cnnn1CCNc1c3c(nc4ccccc14)CCCC3)c1cc(N)ccc21","inchiKey":"ISUOMOOYAOQQPZ-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL117651","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03005"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200764","canonicalSmiles":"CC(=O)OC(C)C[N+](C)(C)C.[Cl-]","inchiKey":"JHPHVAVFUYTVCL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"METHACHOLINE CHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL978","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Provocholine"],"synonyms":["Methacholine chloride","NSC-757090"],"crossReferences":{"DailyMed":["methacholine%20chloride"],"PubChem":["144203899","170464971","50105745","56423647","855729"],"chEBI":["50142"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for asthma. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201112","canonicalSmiles":"COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"IXOXBSCIXZEQEQ-UHTZMRCNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NELARABINE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arranon","Atriance"],"synonyms":["506U","506U78","Attriance","GW-506U78","MAY","NSC-686673","NSC-755985","NSC-759876","Nelarabine","Nelzarabine"],"crossReferences":{"DailyMed":["nelarabine"],"PubChem":["144206267","170464759"],"Wikipedia":["Nelarabine"],"drugbank":["DB01280"],"chEBI":["63612"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for neoplasm and t-cell acute lymphoblastic leukemia and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201368","canonicalSmiles":"CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)O","inchiKey":"ODAIHABQVKJNIY-PEDHHIEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERINDOPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perindopril diacid form","Perindopril related compound b","Perindoprilat","S-9780"],"crossReferences":{"drugbank":["DB14213"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213456","canonicalSmiles":"COc1c(N2C[C@@H](C)C[C@H](N)C2)ccc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"AVPQPGFLVZTJOR-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEMONOXACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nemonoxacin","TG-873870"],"crossReferences":{"drugbank":["DB06600"]},"childChemblIds":["CHEMBL1213283"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1230662","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C","inchiKey":"JUJIMRZGUBTJRV-NASSWSRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230662","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231329","canonicalSmiles":"O=C(O)c1c(C(=O)O)c(C(=O)O)c(C(=O)O)c(C(=O)O)c1C(=O)O","inchiKey":"YDSWCNNOKPMOTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELLITIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzenehexacarboxylic Acid","Mellitic Acid"],"crossReferences":{"drugbank":["DB01681"],"chEBI":["41089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232305","canonicalSmiles":"Nc1ccn([C@H]2CC[C@@H](COP(=O)(O)O)O2)c(=O)n1","inchiKey":"RAJMXAZJKUGYGW-POYBYMJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232305","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02883"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233851","canonicalSmiles":"O=C1N[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)N2C1=O","inchiKey":"OIURYJWYVIAOCW-PQMKYFCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KIFUNENSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kifunensine"],"crossReferences":{"drugbank":["DB02742"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235837","canonicalSmiles":"CC1(C)COC(=O)CCCCCCCCCCCOC(=O)[C@@H]2CCCCN2C(=O)C1=O","inchiKey":"VUCSBBBCFXBFFY-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235837","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08520"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL124660","canonicalSmiles":"COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1","inchiKey":"UXXQOJXBIDBUAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANDUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT 53518","CT-53518","CT53518","MLN-518","Mln-0518","NSC-759851","Tandutinib"],"crossReferences":{"PubChem":["103905342","124950156","144206917","170466826","50100108"],"drugbank":["DB05465"],"chEBI":["90237"]},"linkedTargets":{"rows":["ENSG00000157404","ENSG00000113721","ENSG00000122025"],"count":3},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000630","EFO_0000349","EFO_1001465","EFO_0000222","EFO_0002499","EFO_0002501","EFO_0000519"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL126506","canonicalSmiles":"COc1cc(CC(C)N)cc2c1OCO2","inchiKey":"YQYUWUKDEVZFDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL126506","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01442"]},"childChemblIds":["CHEMBL2361340"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1339","canonicalSmiles":"CCCc1nc(C)c2c(O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12.Cl","inchiKey":"XCMULUAPJXCOHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARDENAFIL HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1520","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levitra","Staxyn","Vardenafil hydrochloride"],"synonyms":["BAY 38-9456","BAY-38-9456","Nuviva","Vardenafil hcl","Vardenafil hydrochloride","Vardenafil hydrochloride anhydrous","Vardenafil hydrochloride hydrate","Vardenafil hydrochloride trihydrate","Vardenafil monohydrochloride"],"crossReferences":{"DailyMed":["vardenafil%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0004234"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for erectile dysfunction."}
{"id":"CHEMBL1411693","canonicalSmiles":"COc1cc(C)nc(-n2nc(C)cc2OC)n1","inchiKey":"RHAXSHUQNIEUEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPIRIZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA-398","Epirizole","Mebron","Mepirizole","Methopyrimazole"],"crossReferences":{"PubChem":["11112646","11532970","144204135","170465827"],"drugbank":["DB08991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1451116","canonicalSmiles":"IC(I)I","inchiKey":"OKJPEAGHQZHRQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOFORM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iodoform","Iodoformum","NSC-26251"],"crossReferences":{"PubChem":["144204675","144209587","144213091","17389850","26752992"],"Wikipedia":["Iodoform"],"drugbank":["DB13813"],"chEBI":["37758"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1457","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"LLPOLZWFYMWNKH-CMKMFDCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCODONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocodone"],"crossReferences":{"DailyMed":["hydrocodone%20bitartrate"],"PubChem":["29215221"],"Wikipedia":["Hydrocodone"],"drugbank":["DB00956"],"chEBI":["5779"]},"childChemblIds":["CHEMBL3989677","CHEMBL1201470","CHEMBL3182640","CHEMBL2062267","CHEMBL2135756"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003943","EFO_0005762","EFO_0003086","HP_0012532","HP_0012735","EFO_0010072","EFO_0003843","HP_0002018","EFO_0003966","EFO_0000546","EFO_0003890","EFO_0001421","HP_0003419","HP_0002013","EFO_0005611","EFO_0009620","MONDO_0005178","EFO_1001250","EFO_0009615"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and cough and has 15 investigational indications."}
{"id":"CHEMBL1463345","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]21CCC(=O)O1","inchiKey":"UJVLDDZCTMKXJK-WNHSNXHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANRENONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Carcinogenicity"],"year":1986},"tradeNames":[],"synonyms":["Canrenone","NSC-261713","SC-9376","Spironolactone metabolite m1","Spironolactone related compound a"],"crossReferences":{"PubChem":["144205004","170466206","49646110"],"drugbank":["DB12221"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["MONDO_0001134","EFO_0000275","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease. It was withdrawn in Germany  in 1986 due to Carcinogenicity."}
{"id":"CHEMBL1480","canonicalSmiles":"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl","inchiKey":"RZTAMFZIAATZDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FELODIPINE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cabren","Cardioplen xl","Felodipine","Felogen xl","Felotens xl","Folpik xl","Keloc sr","Neofel xl","Parmid xl","Pinefeld xl","Plendil","Preslow","Vascalpha"],"synonyms":["C08CA02","Felodipine","H 154/82","H-154/82","NSC-760343"],"crossReferences":{"DailyMed":["felodipine"],"PubChem":["124880165","144203706","170464849","17405071","50106289","50106290","85231057","90340828"],"Wikipedia":["Felodipine"],"drugbank":["DB01023"],"chEBI":["585948"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067","ENSG00000151623"],"count":5},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0001645","EFO_0000319","MONDO_0005148","EFO_0000400","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL1488","canonicalSmiles":"O=c1[nH]cc(N(CCCl)CCCl)c(=O)[nH]1","inchiKey":"IDPUKCWIGUEADI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URACIL MUSTARD","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uracil mustard"],"synonyms":["NSC-34462","U-8344","Uracil mustard","Uramustine"],"crossReferences":{"PubChem":["144205464","29216259","92079"],"Wikipedia":["Uramustine"],"drugbank":["DB00791"],"chEBI":["9884"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962 and is indicated for neoplasm."}
{"id":"CHEMBL154","canonicalSmiles":"COc1ccc2cc([C@H](C)C(=O)O)ccc2c1","inchiKey":"CMWTZPSULFXXJA-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NAPROXEN","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aleve","Anaprox","Arthrosin 250","Arthrosin 250 ec","Arthrosin 500","Arthrosin 500 ec","Condrotec","Ec-naprosyn","Equiproxen","Feminax ultra","Grenoxal","Kenosyn","Laraflex","Napratec op","Naprosyn","Naprosyn 375","Naprosyn ec","Naproxen","Nycopren","Pranoxen continus","Prosaid","Rheuflex 250","Rheuflex 500","Rimoxyn","Stirlescent","Timpron","Timpron 250 ec","Timpron 500 ec","Valrox","Vimovo"],"synonyms":["Aleve","Anaprox","NSC-750183","NSC-757239","Naprelan","Naproxen","PN400 COMPONENT NAPROXEN","RS-3540"],"crossReferences":{"DailyMed":["naproxen","naproxen%20sodium"],"PubChem":["11112669","144212270","26755231","90341518"],"TG-GATEs":["73"],"Wikipedia":["Naproxen"],"drugbank":["DB00788"],"chEBI":["7476"]},"childChemblIds":["CHEMBL1200806"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1001896","EFO_0004274","MONDO_0007254","EFO_0009846","HP_0000132","HP_0011868","EFO_0003964","HP_0002829","MONDO_0005277","HP_0004398","EFO_0003931","MONDO_0002471","EFO_1000786","EFO_0000673","EFO_0004616","HP_0003419","EFO_0005762","Orphanet_144","EFO_0000685","Orphanet_609","EFO_0005856","HP_0001945","EFO_0010072","EFO_0003898","HP_0003418","EFO_0004607","EFO_0003843","HP_0002315","EFO_0005757","EFO_0002609","EFO_0007214","EFO_0005755","EFO_1000941","EFO_0000546","EFO_0009454","MP_0001845","HP_0003326","MONDO_0100096","MONDO_0003937","MONDO_0005301","EFO_0000731","HP_0002653","MONDO_0004975","HP_0100607","MONDO_0002258","MONDO_0005178","EFO_1001887","EFO_0009637","MONDO_0004857","EFO_1001434"],"count":50},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 25 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1601669","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O","inchiKey":"OFHCOWSQAMBJIW-AVJTYSNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFACALCIDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alfa d","Etalpha","One-alpha"],"synonyms":[".alpha.-calcidol","1-alpha-vitamin d","1-hydroxycholecalciferol","1-hydroxyvitamin d3","1.alpha-hydroxycholecalciferol","1.alpha.(oh)d3","1.alpha.-hydroxycholecalciferol","1.alpha.-hydroxyvitamin d3","Alfacalcidol","Alfarol","Alpha d3","Alphacalcidol","Alpharol","Alsiodol","Bondiol","Einsalpha","Oxydevit","Tevabone","Un alfa","Un alpha"],"crossReferences":{"PubChem":["50125753"],"drugbank":["DB01436"],"chEBI":["31186"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0002970","EFO_1001173","EFO_0000401","EFO_0004278","EFO_0003882","EFO_1002048","EFO_0000660","EFO_0002690","EFO_0000544","EFO_0003854","EFO_0004273","EFO_0003884","EFO_0003837","MONDO_0004979"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL163672","canonicalSmiles":"CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1","inchiKey":"KLOIYEQEVSIOOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHROMONAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbocromen"],"crossReferences":{"Wikipedia":["Carbocromen"],"drugbank":["DB13279"]},"childChemblIds":["CHEMBL2104512"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL169046","canonicalSmiles":"C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"INBGSXNNRGWLJU-ZHHJOTBYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"25-Hydroxycholesterol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["25-Hydroxycholesterol"],"crossReferences":{"PubChem":["144206343","50125921"],"drugbank":["DB04705"],"chEBI":["42977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743037","drugType":"Antibody","blackBoxWarning":false,"name":"LORVOTUZUMAB MERTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUN901-DM1, BB-10901","IMGN-901","Lorvotuzumab mertansine"],"linkedTargets":{"rows":["ENSG00000149294","ENSG00000167553","ENSG00000261456","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":16},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000702","EFO_0002918","EFO_0009052","EFO_0001378","EFO_0000760","EFO_0001376","EFO_0000621","Orphanet_654"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL190","canonicalSmiles":"Cn1c(=O)c2nc[nH]c2n(C)c1=O","inchiKey":"ZFXYFBGIUFBOJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOPHYLLINE","yearOfFirstApproval":1940,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accurbron","Aerolate","Aerolate iii","Aerolate jr","Aerolate sr","Aquaphyllin","Bronkodyl","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin sa","Nuelin sa-250","Pro-vent","Quibron","Quibron-t","Quibron-t/sr","Respbid","Slo-bid","Slo-phyllin","Somophyllin-crt","Somophyllin-t","Sustaire","T-phyl","Theo-24","Theo-dur","Theobid","Theobid jr.","Theochron","Theocin","Theoclear l.a.-130","Theoclear l.a.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-sr","Theolixir","Theophyl","Theophyl-225","Theophyl-sr","Theophylline","Theophylline-sr","Theovent","Uni-dur","Uniphyl","Uniphyllin continus"],"synonyms":["Dimethylxanthine","Doxophylline metabolite m3","NSC-2066","NSC-757346","Theophylline","Theophylline anhydrous","Theophylline melting point standard","Theophylline monohydrate","Theophylline, anhydrous","Theophylline,anhydrous"],"crossReferences":{"DailyMed":["aminophylline","theophylline"],"PubChem":["104171361","144204378","144209573","144210348","170466874","17389715","174007168","50103998","56463437","68760","855679","90341676"],"TG-GATEs":["96"],"Wikipedia":["Theophylline"],"drugbank":["DB00277"],"chEBI":["28177"]},"childChemblIds":["CHEMBL1355736","CHEMBL1200434","CHEMBL2104089","CHEMBL2107084","CHEMBL1370561"],"linkedTargets":{"rows":["ENSG00000152270","ENSG00000282608","ENSG00000065989","ENSG00000128271","ENSG00000105650","ENSG00000170425","ENSG00000163485","ENSG00000113448","ENSG00000172572","ENSG00000184588"],"count":10},"linkedDiseases":{"rows":["EFO_0009686","Orphanet_79443","EFO_0001361","EFO_0003086","MONDO_0002009","HP_0001919","EFO_0000222","EFO_1000782","EFO_1002048","EFO_0003060","HP_0002315","EFO_0001663","MONDO_0001187","HP_0002110","EFO_0000565","Orphanet_665","HP_0006536","MONDO_0002050","EFO_0003884","EFO_0006505","MONDO_0004979","EFO_0000341","EFO_0003917","EFO_0000763","HP_0002104","EFO_0009492"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1940 and has 3 approved and 22 investigational indications."}
{"id":"CHEMBL1910411","canonicalSmiles":"CN(C)[C@H]1C[C@@H](C(C)(C)CO)Nc2ccc([N+](=O)[O-])cc21","inchiKey":"YNYAUBNZRZVNLX-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1910411","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1961797","canonicalSmiles":"CCCCCNC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1","inchiKey":"PPUYOYQTTWJTIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR9011","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006959"],"drugbank":["DB14014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19892","canonicalSmiles":"O=c1[nH]c2cc(C(F)(F)F)c(N3CCOCC3)cc2n(CP(=O)(O)O)c1=O","inchiKey":"WZMQMKNCWDCCMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FANAPANEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fanapanel","ZK-200775","ZK200775","Zk200775"],"crossReferences":{"PubChem":["144205298","170466123","29215531"],"drugbank":["DB12393"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2035185","canonicalSmiles":"C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1","inchiKey":"NNXDIGHYPZHXTR-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-1578","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-1578","SB-1578"],"crossReferences":{"drugbank":["DB15294"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL203569","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cc(NC3CCCCC3)nc3ncnn23)cc1","inchiKey":"VPOGRVWIIVMWRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL203569","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07686"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2079699","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM STIBOGLUCONATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3991035","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pentostam"],"synonyms":["Antimony sodium gluconate","Sodium stibogluconate","Sodium stibogluconate anhydrous","Solustibosan"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for leishmaniasis and trypanosomiasis and has 6 investigational indications."}
{"id":"CHEMBL2103983","canonicalSmiles":"[K+].[OH-]","inchiKey":"KWYUFKZDYYNOTN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM HYDROXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caustic potash","Caustic-potash","E-525","INS NO.525","INS-525","Kali causticum","Potassium hydroxide","Potassium hydroxide solution"],"crossReferences":{"drugbank":["DB11153"],"chEBI":["32035"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104528","canonicalSmiles":"CCCCCCC(C)NN","inchiKey":"FODQIVGFADUBKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTAMOXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octamoxin","Octomoxine"],"crossReferences":{"drugbank":["DB09249"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104708","canonicalSmiles":"C[N+](C)(C)NCCC(=O)[O-]","inchiKey":"PVBQYTCFVWZSJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELDONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MET-88","Meldonium","Mildronate","Quaterine"],"crossReferences":{"drugbank":["DB13723"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106004","canonicalSmiles":"CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)Oc3ccccc3NC2=O)cc1","inchiKey":"ZCBJDQBSLZREAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOXATIN ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bisoxatin","Bisoxatin acetate","WY 8138","WY-8138"],"crossReferences":{"PubChem":["144206872"],"drugbank":["DB14654"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106613","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@@]21C","inchiKey":"YUWPMEXLKGOSBF-GACAOOTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANECORTAVE ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL 3789","AL 4940","AL-3789","AL-4940","Anecortave","Anecortave (usan)","Anecortave acetate","NSC-15475","NSC-24345"],"crossReferences":{"PubChem":["144206221"],"drugbank":["DB05288"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2107016","canonicalSmiles":"CN1C(=O)C[C@@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(N)=O)NC1=O","inchiKey":"LQZAIAZUDWIVPM-SRVKXCTJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TALTIRELIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TA-0910","Taltirelin"],"crossReferences":{"PubChem":["144206235"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107818","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"OBMJQRLIQQTJLR-USGQOSEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALDOXORUBICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Inno-206"],"synonyms":["Aldoxorubicin","Doxo-emch","Doxorubicin-emch"],"crossReferences":{"drugbank":["DB06013"]},"childChemblIds":["CHEMBL2107827"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","Orphanet_178","EFO_1001480","EFO_0002517","EFO_0000182","MONDO_0007254","EFO_0000702","EFO_1001968","EFO_0000707","EFO_0003060","EFO_0000519"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL2107825","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1","inchiKey":"LDEKQSIMHVQZJK-CAQYMETFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENOFOVIR ALAFENAMIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gs-7340","Vemlidy"],"synonyms":["GS-7340","GS-734003","Tenofovir alafenamide"],"crossReferences":{"DailyMed":["tenofovir%20alafenamide%20fumarate"],"drugbank":["DB09299"]},"childChemblIds":["CHEMBL2364637"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 4 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108577","drugType":"Cell","blackBoxWarning":false,"name":"BELAGENPUMATUCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lucanix"],"synonyms":["Belagenpumatucel-l"],"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108790","drugType":"Antibody","blackBoxWarning":false,"name":"TELIMOMAB ARITOX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T101","Telimomab aritox"],"linkedTargets":{"rows":["ENSG00000110448"],"count":1},"linkedDiseases":{"rows":["EFO_0004197"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108989","drugType":"Enzyme","blackBoxWarning":false,"name":"ASPARAGINASE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crasnitin","Elspar"],"synonyms":["Asparaginase","Colaspase","E. coli asparaginase","E. coli l-asparaginase","Escherichia coli l-asparaginase","Kidrolase","L-asparaginase","L-asparagine amidohydrolase","NSC-109229"],"crossReferences":{"DrugCentral":["5070"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 4 approved and 21 investigational indications."}
{"id":"CHEMBL2109143","drugType":"Small molecule","blackBoxWarning":false,"name":"METAPROTERENOL POLISTIREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metaproterenol polistirex"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109502","drugType":"Antibody","blackBoxWarning":false,"name":"SGN-15","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-182248","BR-96 CBR96-DOXORUBICIN IMMUNOCONJUGATE","BR96","SGN-15","Sgn-15"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109633","drugType":"Antibody","blackBoxWarning":false,"name":"IMGN-388","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-388","Imgn-388"],"linkedTargets":{"rows":["ENSG00000138448"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL214920","canonicalSmiles":"CC(C)CCOc1ccc(NC(=S)Nc2ccc(OCCC(C)C)cc2)cc1","inchiKey":"BWBONKHPVHMQHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOCARLIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DAT-C","DATC","Isoxyl","NSC-742400","Thiocarlide","Tiocarlide"],"crossReferences":{"Wikipedia":["Thiocarlide"],"drugbank":["DB13608"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2359248","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1","inchiKey":"JKQXZKUSFCKOGQ-QAYBQHTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZEAXANTHIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["African marigold flower","Anchovyxanthin","Aztec marigold flower","Aztec marigold zeaxanthin extract","Big marigold flower","E 161H","E-161H(I)","INS NO.161H(I)","INS-161H(I)","Luteinofta","Optisharp","Tagetes erecta flower","Tagetes ernstii flower","Tagetes excelsa flower","Tagetes heterocarpha flower","Tagetes major flower","Tagetes patula flower","Tagetes remotiflora flower","Xanthophyll 3","Zeagold","Zeaxanthin","Zeaxanthol"],"crossReferences":{"PubChem":["144206223"],"drugbank":["DB11176"],"chEBI":["27547"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2364639","canonicalSmiles":"COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2","inchiKey":"GEJDGVNQKABXKG-CFKGEZKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALBENAZINE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mt-5199","NBI-98854","Valbenazine"],"crossReferences":{"DailyMed":["valbenazine%20tosylate"],"drugbank":["DB11915"]},"childChemblIds":["CHEMBL3707248"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","Orphanet_399","EFO_0004280","EFO_0004895","HP_0012167"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for movement disorder and has 3 investigational indications."}
{"id":"CHEMBL254432","canonicalSmiles":"CCOC(=O)C1=C(C)NC(=S)N[C@H]1c1cccc(O)c1","inchiKey":"LOBCDGHHHHGHFA-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-MENASTROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-Menastrol","S-menastrol"],"crossReferences":{"drugbank":["DB04331"],"chEBI":["75384"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255134","canonicalSmiles":"COc1ccc2c(c1)S(=O)(=O)NC(c1c(O)c(-c3ccccc3)nn(CCC(C)C)c1=O)=N2","inchiKey":"HTTWNUWLEOXVKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL255134","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259771","canonicalSmiles":"CCOC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OCC)c1ccc(-c2nc(N)sc2CC(C)C)o1","inchiKey":"BYKBUQDQTLDNLE-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Mb06322","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mb06322"],"crossReferences":{"drugbank":["DB05518"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL269259","canonicalSmiles":"CC[C@H](C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCc1ccc(OC)c(OC)c1)c1cccc(OCC(=O)NCCNC(=O)COc2cccc([C@@H](CCc3ccc(OC)c(OC)c3)OC(=O)[C@@H]3CCCCN3C(=O)[C@@H](CC)c3cc(OC)c(OC)c(OC)c3)c2)c1)c1cc(OC)c(OC)c(OC)c1","inchiKey":"GQLCLPLEEOUJQC-ZTQDTCGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMIDUCID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP-1903","AP1903","Rimiducid"],"crossReferences":{"drugbank":["DB04974"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL276815","canonicalSmiles":"Cc1onc(O)c1C[C@H](N)C(=O)O","inchiKey":"UUDAMDVQRQNNHZ-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-AMPA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111209","11113389","11113390","11113428","26751663"],"Wikipedia":["AMPA"],"drugbank":["DB02057"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL30054","canonicalSmiles":"O=C(Cn1c(Cl)cnc(NCC(F)(F)c2ccccn2)c1=O)NCc1ncccc1F","inchiKey":"AATHXZYXWMKUFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DPOC-4088","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DP-4088","DPOC 4088","Dpoc-4088"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL303934","canonicalSmiles":"COc1cc(OC)cc(C(=O)N[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NCc4cccc5ccccc45)ncnc32)c1","inchiKey":"OARVXDFNTLYMCJ-JVUUKAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL303934","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039504","canonicalSmiles":"CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1","inchiKey":"MMMVNAGRWOJNMW-FJBFXRHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NINTEDANIB ESYLATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL502835","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ofev"],"synonyms":["Nintedanib esilate","Nintedanib esylate","Nintedanib ethanesulfonate"],"crossReferences":{"DailyMed":["nintedanib%20esylate"],"chEBI":["85170"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000102755","ENSG00000077782","ENSG00000037280","ENSG00000160867","ENSG00000113721"],"count":9},"linkedDiseases":{"rows":["EFO_0000768","EFO_0000717"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for idiopathic pulmonary fibrosis and systemic scleroderma."}
{"id":"CHEMBL333950","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"DTXXSJZBSTYZKE-ZDQKKZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAXACALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prezios"],"synonyms":["1alpha,25-dihydroxy-22-oxavitamin d3","22-oxacalcitriol","Maxacalcitol","OCT","Oxarol","SCH 209579","SCH-209579"],"crossReferences":{"PubChem":["144206553"]},"childChemblIds":["CHEMBL4303452"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL342478","canonicalSmiles":"O=C(O)C(=O)Nc1cc2[nH]ccc2cc1C(=O)O","inchiKey":"AHWMERGBWWROMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL342478","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL353955","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1","inchiKey":"MXHRCPNRJAMMIM-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYURIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxyuridine","Deoxyuridine"],"crossReferences":{"Wikipedia":["Deoxyuridine"],"drugbank":["DB02256"],"chEBI":["16450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544947","canonicalSmiles":"CC(C)(C(N)=O)C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(C(=O)Cc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CCO2)CC1","inchiKey":"ZLNYUCXXSDDIFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BURAPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Burapitant","SSR-240600","SSR240600C","Ssr240600"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545120","drugType":"Small molecule","blackBoxWarning":false,"name":"CE-245677","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ce 245677","Ce-245677"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545177","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-0424","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD0424","Azd-0424"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000197122"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545282","drugType":"Small molecule","blackBoxWarning":false,"name":"KC-706","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ITX 5061","KC-706","KC706","Kc-706"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0004719"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545337","canonicalSmiles":"CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23.Cl.Cl.O","inchiKey":"XJYNBZQTAZDMHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"C-1311","maximumClinicalTrialPhase":2,"parentId":"CHEMBL338604","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Symadex"],"synonyms":["C 1311","C-1311","NSC-645809","Xls-002"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3707314","drugType":"Protein","blackBoxWarning":false,"name":"METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mircera"],"synonyms":["Methoxy polyethylene glycol-epoetin beta","Pegzerepoetin alfa","R-744","R744"],"crossReferences":{"DailyMed":["methoxy%20polyethylene%20glycol-epoetin%20beta"]},"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","MONDO_0002280","EFO_0003884","EFO_0004272"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL3707380","drugType":"Small molecule","blackBoxWarning":false,"name":"RG6029","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0310","Rg6029"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3920982","canonicalSmiles":"O=C(O)c1ccc(C2(NC(=O)C3CC4(CCN3Cc3ccc(C(F)(F)F)cc3)CC4)CC2)cc1","inchiKey":"CADWTPLFEZSAHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CR-6086","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-6086","CR6086","Cr 6086","Cr-6086","Cr6086"],"linkedTargets":{"rows":["ENSG00000171522"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3945728","canonicalSmiles":"O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1","inchiKey":"SQZJGTOZFRNWCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABX-1431","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-1431","ABX1431","Abx-1431"],"linkedTargets":{"rows":["ENSG00000074416"],"count":1},"linkedDiseases":{"rows":["EFO_0004895","EFO_0003843","EFO_0008533"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL394826","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)[nH]c3c2)ccn1","inchiKey":"ZJLSMLDOCGOURY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL394826","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3982690","canonicalSmiles":"Cc1noc(C)c1-c1cc(C(O)(c2ccccn2)c2ccccn2)c2nc(C3CC3)[nH]c2c1","inchiKey":"CMSUJGUHYXQSOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOBRESIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alobresib","Gs 5829","Gs-5829"],"crossReferences":{"drugbank":["DB14970"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989407","canonicalSmiles":"CN1CCC[C@H]1CCNC(=O)c1cn2c3c(c(N4CCC(c5cnccn5)C4)c(F)cc3c1=O)Oc1cc3ccccc3cc1-2","inchiKey":"WOQIDNWTQOYDLF-CGAIIQECSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUARFLOXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX-3543","Itarnafloxin","Quarfloxin"],"crossReferences":{"drugbank":["DB06638"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989476","canonicalSmiles":"CC[C@@]1(OC(=O)[C@H](C)NC(=O)COCCOCC(=O)N[C@@H](C)C(=O)O[C@]2(CC)C(=O)OCc3c2cc2n(c3=O)Cc3cc4ccccc4nc3-2)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1","inchiKey":"DZNNFZGDBUXWMV-ZUWDIFAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEGAMOTECAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prothecan"],"synonyms":["EZ-246","Peg-camptothecin","Pegamotecan"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989697","canonicalSmiles":"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)([O-])O)c2cc1C.O.O.[Na+]","inchiKey":"LQVGUKOCMOKKJU-QPVGXXQTSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOFLAVIN 5'-PHOSPHATE SODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201794","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Photrexa"],"synonyms":["Flavin mononucleotide dihydrate","Phosphated riboflavin","Riboflavin 5'-phosphate sodium","Riboflavin phosphate sodium","Riboflavin sodium phosphate"],"crossReferences":{"DailyMed":["riboflavin%205'-phosphate%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for keratoconus."}
{"id":"CHEMBL3989934","canonicalSmiles":"Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O","inchiKey":"RSNPAKAFCAAMBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVADOMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avadomide","CC-122","CC122"],"crossReferences":{"drugbank":["DB14857"]},"childChemblIds":["CHEMBL3989913"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3989972","canonicalSmiles":"COc1cn(-c2ccc(-n3cccn3)cc2F)nc(-c2ccnn2-c2ccccc2)c1=O","inchiKey":"KVHRYLNQDWXAGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALIPODECT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balipodect","TAK-063"],"crossReferences":{"drugbank":["DB14774"]},"linkedTargets":{"rows":["ENSG00000112541"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL409038","canonicalSmiles":"Nc1nccc(-c2ccc3noc(-c4ccc(Cl)cc4)c3c2)n1","inchiKey":"AQVFETGXIRKVAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL409038","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124950700"],"drugbank":["DB08707"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415879","canonicalSmiles":"c1cnc2c(c1)ccc1cccnc12","inchiKey":"DGEZNRSVGBDHLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENANTHROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,10-Phenanthroline"],"crossReferences":{"PubChem":["11110642","11533040","124876930","144209196","144213428","17388818","17405543","4252490","50105542","50105543","50105544","85230866","90341127"],"Wikipedia":["Phenanthroline"],"drugbank":["DB02365"],"chEBI":["44975"]},"childChemblIds":["CHEMBL1969792","CHEMBL1255788","CHEMBL3183967","CHEMBL1522486"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL426084","canonicalSmiles":"NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3","inchiKey":"RYIDHLJADOKWFM-MAODMQOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMIDORPHAN","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ALKS 33","ALKS-33","ALKS-5461 COMPONENT SAMIDORPHAN","Alks-33","RDC-0313","RDC-0313-00","Samidorphan"],"crossReferences":{"drugbank":["DB12543"]},"childChemblIds":["CHEMBL2105749","CHEMBL471243"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0005203","MONDO_0005090","EFO_0002610","EFO_0009963","MONDO_0007079"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for schizophrenia and bipolar i disorder and has 4 investigational indications."}
{"id":"CHEMBL42710","canonicalSmiles":"C=CCc1ccc(O)c(OC)c1","inchiKey":"RRAFCDWBNXTKKO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EUGENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-allylcatechol 2-methyl ether","Bioxeda","Caryophillic acid","Dentogum","Eugenol","FEMA NO. 2467","NSC-209525","NSC-8895"],"crossReferences":{"PubChem":["144204685","144209238","144210425","170465464","17389879","26747361","26753011","50105594"],"Wikipedia":["Eugenol"],"drugbank":["DB09086"],"chEBI":["4917"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297295","canonicalSmiles":"O=C(NCc1ccc(OC(F)(F)F)c(F)c1)[C@H]1CN(c2nc3nc(C4CC4)ncc3s2)CCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1","inchiKey":"JQLOVYLALGSISI-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JTK-853","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jtk-853"],"crossReferences":{"drugbank":["DB13095"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297367","canonicalSmiles":"C#Cc1cccc(-c2cc(=O)n(C)c3ccc([C@](O)(c4ccc(Cl)cc4)c4cncn4C)cc23)c1","inchiKey":"JAHDAIPFBPPQHQ-GDLZYMKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-609754","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-609,754","Cp-609,754","Cp-609754","LNK-754","Lnk-754","OSI-754"],"crossReferences":{"drugbank":["DB12640"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297400","canonicalSmiles":"CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)c1ccc(-c2nc(N)sc2C(=O)C(C)(C)C)o1","inchiKey":"CTKZZUXRWBCFEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MB-07803","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MB 07803","Mb-07803","Mb07803"],"crossReferences":{"drugbank":["DB05053"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297431","canonicalSmiles":"CCOc1ccc(Cc2cc([C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1F","inchiKey":"HYTPDMFFHVZBOR-VNXMGFANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HENAGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Henagliflozin","SHR-3824","SHR3824","Shr3824"],"crossReferences":{"drugbank":["DB11939"]},"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0001421","MONDO_0005148"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297656","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\\CCCCCCCC)OC(=O)CCCCCCC/C=C\\CCCCCCCC","inchiKey":"PHYFQTYBJUILEZ-IUPFWZBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYL TRIOLEATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glyceryl trioleate","Triolein"],"crossReferences":{"drugbank":["DB13038"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4297753","drugType":"Unknown","blackBoxWarning":false,"name":"FERROUS BISGLYCINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bisglycino-iron(ii) chelate","Ferrochel","Ferrous bisglycinate","Ferrous glycinate","Iron bis-glycinate","Iron bis-glycinate chelate"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297977","drugType":"Unknown","blackBoxWarning":false,"name":"HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen","Hiberix"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298137","canonicalSmiles":"CC1=C[C@@H]2CN(C(=O)N2OS(=O)(=O)O)[C@@H]1C(N)=O","inchiKey":"BISPBXFUKNXOQY-RITPCOANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DURLOBACTAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Durlobactam","EXT2514"],"childChemblIds":["CHEMBL4297378"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL43064","canonicalSmiles":"C(=C/c1ccccc1)\\CN1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"DERZBLKQOCDDDZ-JLHYYAGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINNARIZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marzine r.f.","Mylan travel sickness","Stugeron","Stugeron fte"],"synonyms":["516 MD","516-MD","Aplactan","Aplexal","Artate","Carecin","Cerebolan","Cerepar","Cinaperazine","Cinarizine","Cinazyn","Cinnacet","Cinnageron","Cinnarizine","Cinnipirine","Corathiem","Denapol","Dimitron","Eglen","Folcodal","Giganten","Glanil","Hilactan","Ixertol","Katoseran","Labyrin","Midronal","Mitronal","NSC-758400","Olamin","Processine","R 1575","R 516","R-1575","R-516","Sedatromin","Sepan","Siptazin","Spaderizine","Stugeron","Stunarone","Stutgeron","Stutgin"],"crossReferences":{"PubChem":["144203660","170465920","50103929","56422441","85231348","855570","90340734"],"Wikipedia":["Cinnarizine"],"chEBI":["31403"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001","ENSG00000196639"],"count":5},"linkedDiseases":{"rows":["EFO_0005242","HP_0002321"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for vertigo."}
{"id":"CHEMBL437765","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C","inchiKey":"HJYYPODYNSCCOU-ODRIEIDWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIFAMYCIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CB-01-11","M-14","Rifamicine sv","Rifamycin","Rifamycin Sv","Rifomycin","Rifomycin sv"],"crossReferences":{"DailyMed":["rifamycin%20sodium"],"drugbank":["DB11753"],"chEBI":["29673"]},"childChemblIds":["CHEMBL2105680"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL4594217","canonicalSmiles":"Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.O","inchiKey":"RCCZPUWDQVUJAB-FVYJGOGTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CANAGLIFLOZIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2048484","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Invokana"],"synonyms":["Canagliflozin","Canagliflozin hemihydrate","Canagliflozin hydrate","JNJ-24831754-ZAE","JNJ-28431754","JNJ-28431754-AAA","TA-7284"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0003144","MONDO_0005147","EFO_0000401","MONDO_0007254","EFO_0004194","MONDO_0005148","EFO_0000400","EFO_0000660","EFO_0001073"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4594256","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBAPLATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lobaplatin","NSC-741422"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4594297","canonicalSmiles":"C[Si](C)(C)c1cc([Si](C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O","inchiKey":"TYQIFWXBQYAKCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIROCAFTOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dirocaftor","PTI-808","Pti-808"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594527","drugType":"Unknown","blackBoxWarning":false,"name":"AVID-200","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVID-200","AVID200","Avid-200","Avid200"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650237","drugType":"Cell","blackBoxWarning":false,"name":"ILTAMIOCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMDC","AMDC-USR","Iltamiocel"],"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650307","drugType":"Small molecule","blackBoxWarning":false,"name":"GC-4711","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIS-PROPIONATO(GC4419)","GC-4419 DIPROPIONATE","GC-4711","GC4711","Gc-4711","Gc4711","Rucosopasem manganese"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650308","canonicalSmiles":"Cc1cccc(OC2CCN(Cc3cc(=O)[nH]c(=O)[nH]3)CC2)c1C","inchiKey":"AZOFJHATIPDIER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2556286","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2556286","GSK2556286","Gsk-2556286","Gsk-286","Gsk2556286"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650331","canonicalSmiles":"C[S@+]([O-])CCOc1cc(N2CCN(CCn3c(=O)sc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)c(F)cc1F","inchiKey":"QYCCLUSYHJXDEX-RWYGWLOXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INUPADENANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EOS-100850","EOS100850","Eos100850","Inupadenant"],"childChemblIds":["CHEMBL4650228"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650341","canonicalSmiles":"COC(=O)N1CCC[C@H](NS(C)(=O)=O)[C@@H]1CO[C@H]1CC[C@@H](c2ccccc2)CC1","inchiKey":"UXZAJSZFFARTEI-YRPNKDGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANAVOREXTON","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danavorexton","TAK-925","Tak-925"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL476960","canonicalSmiles":"OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"FZNCGRZWXLXZSZ-CIQUZCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOGLIBOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Basen","Glustat"],"synonyms":["A-71100","AO-128","Voglibose"],"crossReferences":{"PubChem":["144205773","170465993"],"Wikipedia":["Voglibose"],"drugbank":["DB04878"]},"linkedTargets":{"rows":["ENSG00000171298","ENSG00000090402","ENSG00000257335","ENSG00000257743"],"count":4},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0002546","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4802204","drugType":"Unknown","blackBoxWarning":false,"name":"ZORECIMERAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CV-07050101","CV07050101","CVNCOV","Cvncov","Zorecimeran"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL482581","canonicalSmiles":"O=c1ccc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2o1","inchiKey":"XHCADAYNFIFUHF-TVKJYDDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESCULIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-26665"],"crossReferences":{"PubChem":["144204004","26754256"],"Wikipedia":["Aesculin"],"drugbank":["DB13155"],"chEBI":["4853"]},"childChemblIds":["CHEMBL1718108"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL486174","canonicalSmiles":"CCCC[C@@H](O)/C=C(C)/C=C/C=C/C(=O)N1CCCC1=O","inchiKey":"ZYPGADGCNXOUJP-CXVPHVKISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PECILOCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-291839","Pecilocin","Variotin"],"crossReferences":{"Wikipedia":["Pecilocin"],"drugbank":["DB13459"],"chEBI":["32289"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL490814","canonicalSmiles":"C[C@H](Nc1cc2c(-c3cc(Cl)cc(CCCO)c3)noc2cn1)c1ccccc1","inchiKey":"MMGKIHLBFPJYJL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490814","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06897"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL537968","canonicalSmiles":"Cc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)n1","inchiKey":"HNHRWNUXTCATSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL537968","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55624","canonicalSmiles":"Cc1oc(-c2ccccc2)nc1CCC(=O)c1ccc(CC2SC(=O)NC2=O)cc1","inchiKey":"QQKNSPHAFATFNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARGLITAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-86325","Darglitazone"],"crossReferences":{"PubChem":["170466177"],"drugbank":["DB14034"]},"childChemblIds":["CHEMBL2106162"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL557555","canonicalSmiles":"CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O","inchiKey":"KPSRODZRAIWAKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPROFIBRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Modalim"],"synonyms":["Ciprofibrate","NSC-759617","WIN 35833","WIN-35833"],"crossReferences":{"PubChem":["144205674","144208557","144213157","170466356","26757866","50105908","56463556","85230953","90340632"],"Wikipedia":["Ciprofibrate"],"drugbank":["DB09064"],"chEBI":["50867"]},"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL561339","canonicalSmiles":"CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3ccccc32)c(O)c1","inchiKey":"ALGHKWSXJUQNJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADL-5747","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297345"],"linkedTargets":{"rows":["ENSG00000116329"],"count":1},"linkedDiseases":{"rows":["MONDO_0041052","EFO_0004616"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL641","canonicalSmiles":"CNCC[C@@H](Oc1ccccc1C)c1ccccc1","inchiKey":"VHGCDTVCOLNTBX-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ATOMOXETINE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Atomoxetine","Strattera"],"crossReferences":{"DailyMed":["atomoxetine%20hydrochloride"],"PubChem":["11114266"],"Wikipedia":["Atomoxetine"],"drugbank":["DB00289"],"chEBI":["127342"]},"childChemblIds":["CHEMBL1702"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_0005252","EFO_0003768","EFO_0003757","EFO_1001917","EFO_0007191","HP_0100543","MONDO_0002050","MONDO_0005180","EFO_1000645","EFO_0004701","MONDO_0007079","EFO_0005230","EFO_0003877","EFO_0003888","EFO_0005203","HP_0010865","EFO_0003758","EFO_0000311","EFO_0003890","MONDO_0002491","EFO_0004895","MONDO_0005147","MONDO_0004975","HP_0000712","EFO_0005611","EFO_0003918","EFO_0005411"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for attention deficit hyperactivity disorder and has 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL671","canonicalSmiles":"S=P(N1CC1)(N1CC1)N1CC1","inchiKey":"FOCVUCIESVLUNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIOTEPA","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tepadina","Thioplex","Thiotepa"],"synonyms":["NSC-6396","Thiotepa"],"crossReferences":{"DailyMed":["thiotepa"],"PubChem":["124891834","144204952","144214026","26748780","26753739","57260086","72371"],"Wikipedia":["ThioTEPA"],"drugbank":["DB04572"],"chEBI":["9570"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 5 approved and 42 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL677","canonicalSmiles":"C[C@H](N)[C@H](O)c1ccc(O)c(O)c1","inchiKey":"GEFQWZLICWMTKF-CDUCUWFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVONORDEFRIN","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neo-cobefrin"],"synonyms":["(-)-cobefrin","BA 2818","BA-2818","Corbadrine","L-.alpha.-methylnoradrenaline","L-nordefrin","L-norephedrine, 3,4-dihydroxy-","Levonordefrin","NSC-757084","Neo-Cobefrin","Nordefrin","Nordefrin (-)-form","Nordefrin, l-"],"crossReferences":{"PubChem":["11111073","11112447","144205604","170464794"],"Wikipedia":["Levonordefrin"],"drugbank":["DB06707"],"chEBI":["10304"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL7301","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1","inchiKey":"AKJHMTWEGVYYSE-FXILSDISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENRETINIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-HPR","All-trans-4'-hydroxyretinanilide","Fenretinide","MCN-R-1967","N-(4-hydroxyphenyl)retinamide","NSC-760419","Retinamide, n-(4-hydroxyphenyl)-","Rii retinamide"],"crossReferences":{"PubChem":["144204558","144208187","170466359","17389243","26752780","26752781","26752782","26752783","49718105","50105427","50105428","50105430","577595","90341414","92763796"],"Wikipedia":["Fenretinide"],"drugbank":["DB05076"],"chEBI":["42588"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL75691","canonicalSmiles":"Clc1ccc(-c2cc(C3CCNCC3)[nH]n2)cc1","inchiKey":"GELALLNTKKLQLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL75691","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24817352"],"drugbank":["DB08061"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL905","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12","inchiKey":"ULFRLSNUDGIQQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIZATRIPTAN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxalt"],"synonyms":["L-705126","MK-462","MK-462 FREE BASE","Maxalt","Maxalt-Mlt","Rizatriptan"],"crossReferences":{"DailyMed":["rizatriptan%20benzoate"],"PubChem":["144205087","174007052"],"Wikipedia":["Rizatriptan"],"drugbank":["DB00953"],"chEBI":["48273"]},"childChemblIds":["CHEMBL1201032","CHEMBL3989629"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0100431","MONDO_0005277","MONDO_0005475"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for migraine disorder and has 2 investigational indications."}
